Klinische Notizen zu medizinischen Codes. KI-basiert. Kostenlos.

MedAPI.ai ist ein KI-gestützter Dienst für medizinisches Coding — per Websuche und REST-API. Gedeckte Vorschläge aus offiziellen Systematik-Inhalten, validiert gegen die autoritative Datenbank.

Codierungssysteme

Semantisches RAG-Retrieval, gedeckte Code-Vorschläge mit Confidence-Werten und Validierung gegen die autoritative Datenbank — über die unterstützten Codierungssysteme hinweg.

API

POST /api/code und GET /api/describe — Integration in KIS, Abrechnung und Forschung.

Z79.634

ICD-10-CM 2027 · Abrechenbar

Long term (current) use of topoisomerase inhibitor

Geschwistercodes

  • Z79.630 – Long term (current) use of alkylating agent
  • Z79.631 – Long term (current) use of antimetabolite agent
  • Z79.632 – Long term (current) use of antitumor antibiotic
  • Z79.633 – Long term (current) use of mitotic inhibitor

Inclusion terms

  • Long term (current) use of etoposide
  • Long term (current) use of irinotecan
  • Long term (current) use of topotecan

Vererbt von Z79.6: Long term (current) use of immunomodulators and immunosuppressants

Excludes2

  • long term (current) use of steroids (Z79.5-)
  • long term (current) use of agents affecting estrogen receptors and estrogen levels (Z79.81-)

Vererbt von Z79: Long term (current) drug therapy

Code also

  • any therapeutic drug level monitoring (Z51.81)

Excludes2

  • drug abuse and dependence (F11-F19)
  • drug use complicating pregnancy, childbirth, and the puerperium (O99.32-)

Includes

  • long term (current) drug use for prophylactic purposes

Teil von: Z79.63: Long term (current) use of chemotherapeutic agent › Z79.6: Long term (current) use of immunomodulators and immunosuppressants › Z79: Long term (current) drug therapy